Prevalence and Risk Factors of Elevated Alanine Aminotransferase (ALT) in 2382 Treatment‐naïve HBV/HDV Co‐Infected Patients
In this large cohort of Asian patients, an earlier and more severe inflammatory process could be demonstrated in CHD compared to CHB regardless of liver cirrhosis. Longitudinal studies are warranted to risk-stratify and prioritise patients for therapies.
Authors
- Oyungerel Lkhagva-Ochir
- Karin Lindahl (ORCID: https://orcid.org/0000-0002-3759-8603)
- Michael Ingre (ORCID: https://orcid.org/0000-0003-0678-4494)
- Habiba Kamal (ORCID: https://orcid.org/0000-0002-6662-7813)
- Daniel Bruce
- Ganbolor Jargalsaikhan
- Andreas Bungert (ORCID: https://orcid.org/0000-0003-1515-7759)
- Sanjaasuren Enkhtaivan
- Tuvshinjargal Ulziibadrakh
- Bekhbold Dashtserenx
- Soo Aleman
- Heiner Wedemeyer
- Naranjargal B Dashdorj
- Hannes Hagström
Institutions
- Statistics Sweden (SE)
- Karolinska University Hospital (SE)
- Mongolian University of Life Sciences (MN)
- Karolinska Institutet (SE)
- Medizinische Hochschule Hannover (DE)
- National Center for Communicable Diseases (MN)
Publication Details
- Journal
- Liver International
- Published
- 2026-02-26
- DOI
- https://doi.org/10.1111/liv.70559
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00